Nextera logo
  • About us
    • Management
    • Board of Directors
  • Technology
  • News & Events
  • Careers
  • Contact

Nextera at BIO Europe 2023

Nov 6, 2023 | Meet us, News

CEO/CSO Geir Åge Løset and Head of Business Development Francis Yuan will attend the BIO Europe 2023 in Munich, Germany, November 6 – 8. We are interested in discussing partnerships, collaborations, and asset out-licensing – please get in touch if you would like to meet us.

https://informaconnect.com/bioeurope/

BIO Europe logo
← Previous Next →

Recent

  • Nextera to present at Antibody Engineering & Therapeutics Europe in Basel
  • Nextera receives funding from the Norwegian Research Council through the Innovation Project for the Industrial Sector
  • Nextera present at PEGS Europe 2025 on 11-13 November in Lisbon
  • Nextera AS announces collaboration with Karolinska Institutet for development of novel targeted tolerizing immunotherapy in Rheumatoid Arthritis
  • Nextera Presenting at PEGS Europe 2024 on November 5th in Barcelona

Sort by

  • Meet us
  • News
  • Publications

Nextera AS

Oslo Innovation Centre
Gaustadalléen 21
, 0349 Oslo, Norway
Org. no. NO 994 486 594 MVA Norwegian Register of Business Enterprises

  • Follow

Contact

Phone: +47 930 38 630
Mail: info@nextera.no

Cookie Policy

Copyright 2025 Nextera AS
Design by Færd

Navigation

About us
Management
Board of Directors
Technology
News & Events
Contact

Recent news

Nextera to present at Antibody Engineering & Therapeutics Europe in Basel

May 26, 2026

Nextera AS will attend the upcoming Antibody Engineering & Therapeutics Europe meeting, taking place in Basel, Switzerland from 27–29 May 2026. The conference is a leading international forum for antibody discovery and engineering, bringing together...

Nextera receives funding from the Norwegian Research Council through the Innovation Project for the Industrial Sector

Nov 24, 2025

Nextera is very pleased to announce that the Norwegian Research Council (NRC) has awarded a grant through the Innovation Project for the Industrial Sector (IPN) to support our continued development of TCR-Like antibodies as novel therapy in autoimmune diseases such as...

Copyright 2020 Nextera AS
Design by Færd

Copyright 2020 Nextera AS
Design by Færd